Aims-To analyse the forward scatter/side scatter (FSC/SSC) distribution of acute myeloblastic leukaemia (AML) blast cells in order to assess whether it correlates with their morphology, immunophenotype, and clinical and biological disease characteristics.
Methods-FSCISSC patterns were established upon taking into account the localisation of the residual T lymphocytes in the FSC/SSC dot plot as an internal biological standard. One hundred and seventy one newly diagnosed AML patients were analysed and five different FSC/SSC patterns were established. These five patterns could be grouped into two major categories taking into account the FSC/SSC distribution of normal cells in a bone marrow aspirate: immature patterns (1 and 2) and mature patterns (3, 4, and 5) . These FSC/SSC patterns were correlated with different clinical and biological characteristics of AML patients. Results-No significant associations were detected in relation to the clinical and haematological disease characteristics and the prognosis of these patients. By contrast there was a significant correlation between the FSC/SSC pattern of the AML blast cells and the FAB classification. An increased reactivity for the antigens associated with myeloid differentiation such as CD13, CD33, CD11b, CD15, CD14, CD4, CD56, and/or CD16 was detected among cases showing a mature FSCISSC pattern (3, 4, and 5) , both in the whole series and even within each of the FAB AML subtypes. By contrast, the reactivity for the CD34 precursor cell associated antigen was higher among those cases displaying an immature FSC/SSC pattern, this being observed even within each FAB subgroup. Conclusions-The FSC/SSC pattern distribution of AML blast cells not only provides an additional objective and reproductible system for the classification of these leukaemias but it may also represent a connection between the FAB morphological groups and the immunophenotypic classification ofAML patients. (J7 Clin Pathol 1995;48:456-462) Keywords: Acute myeloblastic leukaemia, light scatter, immunophenotype, morphology.
The French-American-British Cooperative Group (FAB) classification,'2 which is based on both morphological and cytochemical criteria, is the most widely accepted and used classification for the acute leukaemias. However, this classification has received criticism from several sources, mainly because of discrepancies among different observers.3`6 This has led other groups to propose alternative classifications, some of which include cytogenetic and immunophenotypic criteria.79
At present, immunophenotypic studies on patients with acute myeloblastic leukaemia (AML) frequently combine the use of monoclonal antibodies and flow cytometry. Two types of index can be measured: that related to the light scatter, and that associated with the presence of fluorochromes in a cell.'01' Measurements of the low angle forward light scatter (FSC) and the orthogonal light scatter (SSC) have been shown to provide information about cell size, asymmetry, and viability, as well as on the internal complexity of the cell.'0"1 Thus the combination of these two light scatter indices allows the identification of different leucocyte subpopulations in both peripheral blood and bone marrow.'0-12 Analysis of AML blast cells combining monoclonal antibodies and flow cytometry may therefore provide information not only on the phenotypic characteristics of the blast cells but also on their FSC/SSC features. Up to now no account has been taken of the distribution pattern of AML blast cells according to their light scatter properties in most immunophenotypical studies on AML patients. This is probably because it has been shown that there is no absolute correlation between this morphological information obtained using flow cytometry and the FAB classification. 12 The aim of the present study was to analyse the FSC/SSC distribution of AML blast cells in order to assess whether or not it correlates with their morphology, immunophenotype, and clinical and biological disease characteristics.
Methods

PATIENTS
One hundred and seventy one untreated patients with de novo AML diagnosed according to the FAB criteria'2 were included in the study.
Patients under 65 years old and older patients in otherwise good physical health were treated according to a standard protocol which included daunorubicin (60 mg/m2 for three days) and Ara-C (200 mg/M2 for seven days). The criteria of Ellison et al'3 were used to ascertain the achievement of complete remission.
IMMUNOLOGICAL PHENOTYPE
For the immunophenotypic characterisation of the AML blast cells a panel of monoclonal antibodies (Mab) was used: the specificity of these Mab has been described elsewhere.71415
This panel included markers against the different myeloid lineages, as well as several Mab for precursor cells and other markers directed against lymphoid T, B, and natural killer (NK) cell linages. All cases were tested for at least one specific Mab for all the different cell lineages, using double and triple staining procedures. The Mab used were: FMC56 (CD9); 3C5, HPCA-1, HPCA-2 (CD34); anti-HLA-DR; My7, Leu M7 (CD13); My9, Leu M9 (CD33); Leu 15 (CD11b); Leu MI (CD15), Leu M3 (CD 14); anti-glycophorin A; antitransferrin receptor (CD71); anti-GPIIIa (CD61);J15 (CD41); AN51, FMC25 (CD42); anti-TdT; Leu 12 (CD 19); Leu 9 (CD7); Leu 5b (CD2); Leu 4 (CD3); Leu 3a (CD4); Leu 2 (CD8); Leu 19 (CD56); Leu llc (CD16).
Analysis of cell reactivity with the different Mab combinations was performed on an FAC-Scan flow cytometer (Becton Dickinson), equipped with an argon ion laser tuned at 488 nm and 15 mW. Results were analysed for at least 4000 cells per test, using the LYSIS-II and PAINT-A-GATE software programs (Becton Dickinson). An antigen was considered to be positive when at least 15% of the blast cells expressed this marker. Erythroblasts were excluded from the analysis gate used for the M6 leukaemia blast cells. Results expressed as mean (SD) and median.
ofresidual T lymphocytes. In the cases included as pattern 2, blast cells accumulated in a FSC/ SSC region corresponding to that of myeloid CD34 + precursor cells in normal bone marrow samples, displaying a slightly higher FSC and a similar or slightly higher SSC than that of T lymphocytes. Thus in pattern 2, blast cells appeared as a prolongation of the T lymphocytes in the FSC/SSC dot plots (fig 1) . Pattern 3 was characterised by having an FSC identical to that of T lymphocytes and a heterogeneous SSC always higher than that of T cells. Blast cells ofthe cases classified as pattern 4 displayed identical FSC/SSC characteristics to those of monocytes. In pattern 5, blast cells were clearly separated from the T cells because they displayed both a higher FSC and a greater SSC. These five FSC/SSC patterns were grouped into two major groups: mature cases (patterns Results Table 1 shows the distribution of patients according to the FSC/SSC pattern of their blast cells. The most frequent FSC/SSC pattern was number 4 (33%), while pattern 3 was the least common one (5%); similar frequencies were observed for pattern 1 (20%), pattern 2 (25%), Results expressed as mean (SD) of positive blast cells and percentage of positive AML cases. and pattern 5 (17%). Upon grouping the FSC/ SSC patterns into mature and immature, almost half of the patients were included in each group (55% and 45%, respectively). On the basis of "visual" criteria, three different observers analysed and classified the patients according to the FSC/SSC pattern of their blast cells; the concordance between them was 86%. The clinical and biological characteristics of the AML patients according to their FSC/SSC characteristics are shown in tables 1 and 2. No major differences were observed between them, with the exception of a higher incidence of hepatomegaly in those cases displaying either pattern 3 or pattern 4 (p = 0 04) and a greater peripheral blood white cell count in pattern 4 patients (p = 0 02). Upon comparing the distribution of the different FAB morphological subgroups in each of the FSC/SSC patterns, a statistically significant correlation (p = 0 0002) was detected between the two classifications (table 3) . Eighty percent of the MO and Ml AML cases displayed immature FSC/SSC patterns (patterns 1 and 2) while M2 and M3 cases showed a heterogeneous distribution, 40% of the M3 leukaemias corresponding to the mature pattern 5. Forty six percent of the M4 patients, 52% of all M5 patients, and 81% of the M5b patients were included in pattern 4. Moreover, 73% of the M4 patients and 72% of the M5 patients had mature FSC/SSC patterns (patterns 3, 4, and 5). By contrast, most of the M6 (75%) and all of the M7 AML cases displayed either pattern 1 or pattern 2. We also analysed whether or not the FSC/ SSC pattern of blast cells within each FAB subtype correlated with cell differentiation, as shown by the expression of distinct cell surface markers. Upon grouping our patients into immature and mature FSC/SSC cases, important phenotypic differences were detected for each morphological subtype; these are shown in tables 4-8. Both M6 and M7 leukaemias were excluded from the analysis since in the present series few cases were included in either of these FAB subtypes. Statistically significant differences between Ml cases with immature or mature FSC/SSC patterns were detected for antigens CD33 (44(SD 31) v 73 (19) ; p = 0 05), CDllb (13(12) v 33(20); p=0 05), and CD14 (2(3) v 6(2); p=0 04) (table 4). Regarding M2 leukaemias, a lower expression of antigens CD14 (1(2) v 12(26); p=0 05) and HIA-DR (34(30) v 26(35); p=0 02) was detected in patients with an immature FSC/SSC pattern (table 5). In the M3 AML cases with an immature FSC/SSC pattern, a lower reactivity for the CD13 antigen (69(17) v 85(16); p=0 01) was detected (table 6 ). In addition, M4 cases with an immature FSC/SSC pattern showed a lower reactivity for antigens CD1 lb (18(24) v 48(34); p=0 03), CD14 (5(5) v 33(31); p= 0-03), and CD56 (0(0) v 39(32); p=0005) (table 7) . Likewise, AML patients classified as M5 leukaemias with an immature light scatter pattern had a significantly lower reactivity for antigens CD33 (42(31) v 78(29); p=00009), CD11b (25(23) v 61(36); p=001), CD15 (15(27) v 61(39); p=0 01), CD4 (35(27) v 60(30); p=0 006), and CD16 (0(0) v 29(25); p = 0 002) (table 8). No statistically significant differences were detected for the expression of other antigens analysed, although the expression ofthe CD34 antigen was always higher in the cases in which cells displayed an immature FSC/SSC pattern (tables 4-8). Regarding the analysis of the prognostic impact of the FSC/SSC pattern of the leukaemic blast cells, no statistically significant differences were detected with respect to either the complete remission rate (pattern 1: 74%; pattern 2: 70%; pattern 3: 80%; pattern 4: 70%; pattern 5: 80%) or survival, although the patients with FSC/SSC pattern 5 had a slightly better outcome (figs 2 and 3).
Discussion
The morphological classification of AML proposed by the FAB group is limited to subjective interpretation, and the degree of agreement obtained between different observers, even experts, is usually lower than 70%.3561718 These problems have led several groups to propose alternative classifications, incorporating other 460 I 1 aspects, such as the morphological, immunological, and cytogenetic (MIC)9 and im-munophenotypic7 classifications of AML.
Flow cytometry provides information on both the immunophenotype and the morphology associated characteristics of blast cells, as assessed by their FSC/SSC properties.'0"' To the best of our knowledge, there has only been one attempt to group AML patients according to the light scatter properties of the leukaemic cells. 2 In that study AML cases were divided into nine different categories that were grouped into three different FSC/SSC patterns, and their correlation with the FAB classification was analysed.
In the present paper the light scatter characteristics of 171 newly diagnosed AML patients were analysed. In contrast to normal peripheral blood or bone marrow samples, leukaemic specimens showed quite a homogeneous FSC/SSC distribution. This is related to the monomorphic morphology displayed by leukaemic compared with normal samples. When examining the FSC/SSC distribution of normal bone marrow cells,'9 a correlation between the light scatter properties of the leukaemic blast cells and that of normal myeloid cells can be established. Five different FSC/SSC patterns were determined by taking the FSC/SSC of the residual T lymphocytes as a reference. These five patterns could be grouped into two major categories: (1) immature patterns: cases displaying FSC/SSC patterns that overlap those of normal myeloid precursor cells (patterns 1 and 2); and (2) mature patterns: those in which leukaemic cells accumulate in regions corresponding to more mature monocytic (pattern 4) or granulocytic cells (patterns 3, 4, and 5). The existence of a clear cutoff between T lymphocytes and blast cells would allow a good discrimination between the two groups of patients. Interestingly, a high reproducibility (86%) was found in the present study for this classification, even when only a subjective interpretation of the FSC/ SSC dot plots was performed and the values of the arbitrary unit (channel) for these cell populations were not considered.
Upon grouping the AML patients according to the FSC/SSC pattern of their blast cells no major differences were observed regarding the clinical and biological disease characteristics of the different groups, with the exception of higher mean peripheral blood white cell counts in pattern 4, and a high frequency of hepatomegaly in patterns 3 and 4. This is probably because of the higher incidence of monocytic leukaemias detected in this group. In addition, no significant differences in prognosis were detected among the different groups, although there was a slightly better survival rate in patients displaying pattern 5. This was probably related to the high incidence of M3 leukaemias within this FSC/SSC pattern. By contrast, there was a significant correlation between the FSC/ SSC pattern of the AML blast cells and the FAB morphology classification. In this sense, the morphologically undifferentiated cases (MO and M1 cases) were associated with an immature FSC/SSC pattern, while cases dis-playing more mature morphological characteristics (M2, M3, M4, and M5 leukaemias) showed a higher incidence of mature FSC/SSC patterns. However, several FSC/SSC patterns can be found in each FAB morphological subtype. The present results indicate that the FSC/ SSC pattern of blast cells to a large extent reflects the morphological and immunological differentiation associated features of myeloid cells. Accordingly upon analysing the immunological characteristics of the immature versus the mature FSC/SSC patterns, our results showed that this classification of AML cases largely reflects cell differentiation along the monocytic and granulocytic cell lineages and may explain some of the discrepancies detected among the morphological and phenotypic characteristics of AML blast cells. In this sense, an increased reactivity for the antigens associated with myeloid differentiation, such as CD13, CD33, CD1lb, CD15, CD14, CD4, CD56, and CD16, was detected among cases showing a mature FSC/SSC pattern, both in the whole series and even within each of the AML FAB subtypes. By contrast, the reactivity for the CD34 precursor cell associated antigen, even within each FAB subgroup, was higher among the cases with an immature FSC/SSC pattern.
In summary, our results indicate that the FSC/SSC pattern distribution of AML blast cells provides not only additional objective information for the classification of these leukaemias but may also represent the connection between the FAB morphological groups and the immunophenotypic classification of AML patients.
